Clinical Trials

200 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT05415475 2024-01-05

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

36 enrolled

Esophageal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT04266327 2023-12-27

RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes

30 enrolled

Carcinoma, Squamous Cell, Recurrence

NCT03236129 2023-12-18

DLI-Boost

Other hematologic neoplasm

52 enrolled

Recurrence, Hematologic Neoplasms

NCT04636775 2023-12-11

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

82 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06103617 2023-11-18

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

10 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT02624128 2023-11-13

V-CHANCE

39 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06096493 2023-10-23

Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

200 enrolled

Rectal Neoplasms, Recurrence

NCT06088719 2023-10-18

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

300 enrolled

Breast

Breast Neoplasms, Recurrence

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

128 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05626829 2023-10-06

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

18 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT04825496 2023-09-21

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

18 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05304741 2023-08-31

The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening

30 enrolled

Recurrence, Colorectal Neoplasms

NCT05845632 2023-08-16

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

965 enrolled

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence, Skin Neoplasms

NCT05990959 2023-08-14

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

800 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT04969107 2023-08-08

Abdominal or Transanal TME for Rectal Cancer Therapy

300 enrolled

Rectal Neoplasms, Recurrence

NCT03505554 2023-08-07

CRU3

12 enrolled

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT05229471 2023-07-27

REDUCE

220 enrolled

Classical hematology

Neoplasms, Recurrence, Venous Thromboembolism

NCT05951855 2023-07-19

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Other hematologic neoplasm

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05420558 2023-07-17

Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System

100 enrolled

Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Recurrence

NCT02825836 2023-07-13

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Phase 1/2 Unknown

130 enrolled

Lymphoma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05940051 2023-07-11

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

35 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05397184 2023-07-05

TvT CAR7

10 enrolled

Recurrence

NCT04671459 2023-06-28

TaRRGET

40 enrolled

CNS

Glioblastoma, Recurrence

NCT05576532 2023-06-28

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

30 enrolled

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05920876 2023-06-27

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

100 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT05250791 2023-06-09

FLICOR

50 enrolled

Recurrence, Colorectal Neoplasms

NCT05895370 2023-06-08

GI-HPVT-01

12 enrolled

Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT04761146 2023-05-25

DaRT-V

10 enrolled

Gynecologic

Recurrence, Vulvar Neoplasms

NCT05876052 2023-05-25

POTERE

192 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence

NCT05487651 2023-05-18

ANCHOR2

LymphoidOther hematologic neoplasmSarcoma

36 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Phase EARLY_PHASE1 Unknown

15 enrolled

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05816746 2023-05-09

Decitabine and Anti-PD-1 in R/R DLBCL

20 enrolled

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03510767 2023-04-14

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

60 enrolled

Lymphoma, Recurrence

NCT01675219 2023-04-13

Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

400 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

20 enrolled

Recurrence, Lymphoma, B-Cell

NCT05084586 2023-03-28

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

100 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Other hematologic neoplasm

40 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT02761070 2023-03-08

RE-GEND

146 enrolled

CNS

Glioblastoma, Recurrence, Disease Progression

NCT05738668 2023-02-22

Bio-NMDAr

400 enrolled

Recurrence, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT04933825 2023-02-17

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

18 enrolled

Recurrence

NCT05727683 2023-02-14

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

33 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04113226 2023-02-08

Relyage

114 enrolled

LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT04706936 2023-02-06

Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma